[go: up one dir, main page]

WO2011036637A3 - Milieu de culture de cellules - Google Patents

Milieu de culture de cellules Download PDF

Info

Publication number
WO2011036637A3
WO2011036637A3 PCT/IB2010/054303 IB2010054303W WO2011036637A3 WO 2011036637 A3 WO2011036637 A3 WO 2011036637A3 IB 2010054303 W IB2010054303 W IB 2010054303W WO 2011036637 A3 WO2011036637 A3 WO 2011036637A3
Authority
WO
WIPO (PCT)
Prior art keywords
culture medium
cell culture
cells
provides
culturing human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2010/054303
Other languages
English (en)
Other versions
WO2011036637A2 (fr
Inventor
Henriette Skribek
László SZÉKELY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOMARKER Ltd
Original Assignee
BIOMARKER Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOMARKER Ltd filed Critical BIOMARKER Ltd
Priority to US13/497,707 priority Critical patent/US9790464B2/en
Priority to DK10779041.2T priority patent/DK2480655T3/en
Priority to EP10779041.2A priority patent/EP2480655B8/fr
Priority to ES10779041.2T priority patent/ES2569236T3/es
Publication of WO2011036637A2 publication Critical patent/WO2011036637A2/fr
Publication of WO2011036637A3 publication Critical patent/WO2011036637A3/fr
Anticipated expiration legal-status Critical
Priority to US15/785,011 priority patent/US20180080006A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention porte sur un milieu de culture de cellules pour cultiver des cellules humaines, lequel milieu comprend un matériau de sang total anticoagulé dans lequel le niveau d'hémoglobine est d'environ 8 à environ 16 g/dl. L'invention porte plus particulièrement sur un milieu de culture de cellules dans lequel des cellules présentes dans le sang sont rompues et les restes insolubles des cellules lysées sont retirés. L'invention porte également sur un procédé pour la préparation d'un milieu de culture de cellules pour la culture de cellules humaines.
PCT/IB2010/054303 2009-09-25 2010-09-24 Milieu de culture de cellules Ceased WO2011036637A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US13/497,707 US9790464B2 (en) 2009-09-25 2010-09-24 Cell culture medium
DK10779041.2T DK2480655T3 (en) 2009-09-25 2010-09-24 Cell culture medium
EP10779041.2A EP2480655B8 (fr) 2009-09-25 2010-09-24 Milieu de culture de cellules
ES10779041.2T ES2569236T3 (es) 2009-09-25 2010-09-24 Medio de cultivo celular
US15/785,011 US20180080006A1 (en) 2009-09-25 2017-10-16 Cell culture medium

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUP0900603 2009-09-25
HU0900603A HUP0900603A2 (en) 2009-09-25 2009-09-25 Cell culture medium

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/497,707 A-371-Of-International US9790464B2 (en) 2009-09-25 2010-09-24 Cell culture medium
US15/785,011 Division US20180080006A1 (en) 2009-09-25 2017-10-16 Cell culture medium

Publications (2)

Publication Number Publication Date
WO2011036637A2 WO2011036637A2 (fr) 2011-03-31
WO2011036637A3 true WO2011036637A3 (fr) 2011-06-16

Family

ID=89989267

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2010/054303 Ceased WO2011036637A2 (fr) 2009-09-25 2010-09-24 Milieu de culture de cellules

Country Status (7)

Country Link
US (2) US9790464B2 (fr)
EP (1) EP2480655B8 (fr)
DK (1) DK2480655T3 (fr)
ES (1) ES2569236T3 (fr)
HU (1) HUP0900603A2 (fr)
PL (1) PL2480655T3 (fr)
WO (1) WO2011036637A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016207721A1 (fr) 2015-06-25 2016-12-29 University Of Limerick Dispositif mécanique de production de bibliothèque combinatoire
WO2017156341A1 (fr) * 2016-03-09 2017-09-14 Beijing Percans Oncology Co. Ltd. Cultures en suspension de cellules tumorales et procédés associés

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102395A1 (fr) * 2001-06-18 2002-12-27 S.A.V Virex Co Ltd Extrait de nerium oleander, compositions contenant cet extrait de nerium oleander l. et procede permettant de preparer cet extrait
WO2008077638A1 (fr) * 2006-12-22 2008-07-03 Horst Kief Cultures de sang total à cellules immunitaires stimulées et utilisation de celles-ci comme agents thérapeutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801537D0 (sv) * 1988-04-26 1988-04-26 Ellco Food Ab Cellodlingsmedium samt forfarande for dess framstellning
GB0108143D0 (en) * 2001-03-31 2001-05-23 Univ Dundee High-throughput screen
WO2003048313A2 (fr) * 2001-11-30 2003-06-12 Invitrogen Corporation Produits de culture cellulaire sous forme de poudre seche contenant des lipides et procedes de production correspondants
WO2007044427A2 (fr) * 2005-10-05 2007-04-19 Panomics, Inc. Détection d’acides nucléiques provenant de sang total
CN102574901B (zh) * 2009-05-07 2016-08-03 埃玛里纳 新的血红蛋白及其用途

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102395A1 (fr) * 2001-06-18 2002-12-27 S.A.V Virex Co Ltd Extrait de nerium oleander, compositions contenant cet extrait de nerium oleander l. et procede permettant de preparer cet extrait
WO2008077638A1 (fr) * 2006-12-22 2008-07-03 Horst Kief Cultures de sang total à cellules immunitaires stimulées et utilisation de celles-ci comme agents thérapeutiques

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ALSOUSOU J ET AL: "The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature.", THE JOURNAL OF BONE AND JOINT SURGERY. BRITISH VOLUME AUG 2009 LNKD- PUBMED:19651823, vol. 91, no. 8, August 2009 (2009-08-01), pages 987 - 996, XP009145933, ISSN: 0301-620X *
AROSA FAPEREIRA CFFONSECA AM: "Red blood cells as modulators of T cell growth and survival", CURR PHARM DES, vol. 10, 20 April 2001 (2001-04-20), pages 191 - 201, XP009145923 *
FONSECA ANA MAFALDA ET AL: "Red blood cells upregulate cytoprotective proteins and the labile iron pool in dividing human T cells despite a reduction in oxidative stress", FREE RADICAL BIOLOGY AND MEDICINE, ELSEVIER SCIENCE, US, vol. 35, no. 11, 1 December 2003 (2003-12-01), pages 1404 - 1416, XP009145922, ISSN: 0891-5849 *
GASZLING V L W ET AL: "Platelet-rich Plasma and Platelet-rich fibrin in human cell culture", ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY, ORAL RADIOLOGY AND ENDODONTICS, MOSBY-YEAR BOOK, ST. LOUIS, MO, US, vol. 108, no. 1, 1 July 2009 (2009-07-01), pages 48 - 55, XP026434161, ISSN: 1079-2104, [retrieved on 20090517] *
HOCHART HELENE ET AL: "Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.", THROMBOSIS AND HAEMOSTASIS MAR 2008 LNKD- PUBMED:18327406, vol. 99, no. 3, March 2008 (2008-03-01), pages 570 - 575, XP009145928, ISSN: 0340-6245 *
VICENTE MIRABET ET AL: "Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues", CELL AND TISSUE BANKING, KLUWER ACADEMIC PUBLISHERS, DO, vol. 9, no. 1, 20 June 2007 (2007-06-20), pages 1 - 10, XP019570750, ISSN: 1573-6814 *

Also Published As

Publication number Publication date
EP2480655B8 (fr) 2016-08-10
HU0900603D0 (en) 2009-12-28
HUP0900603A2 (en) 2012-02-28
EP2480655A2 (fr) 2012-08-01
ES2569236T3 (es) 2016-05-09
DK2480655T3 (en) 2016-04-25
US20130071925A1 (en) 2013-03-21
EP2480655B1 (fr) 2016-01-27
US9790464B2 (en) 2017-10-17
WO2011036637A2 (fr) 2011-03-31
PL2480655T3 (pl) 2016-10-31
US20180080006A1 (en) 2018-03-22

Similar Documents

Publication Publication Date Title
WO2010096588A3 (fr) Milieu de culture cellulaire contenant des combinaisons de protéines
WO2009145419A9 (fr) Composition comprenant de la peptone végétale pour favoriser la prolifération de cellules souches
WO2012071527A3 (fr) Administration de protéines à partir de microvecteurs de cellules souches
WO2008004990A3 (fr) Procédé de culture de cellules souches et cellules souches ainsi obtenues
CA2801536C (fr) Concentres et isolats de proteines, et processus de confection de ceux-ci a partir de macro-algues et/ou de micro-algues
WO2010107192A3 (fr) Procédé d'isolement et procédé de culture en masse pour des cellules souches pluripotentes dérivées de sang de cordon ombilical exprimant znf281
MX356756B (es) Células madre pluripotentes en microportadores.
WO2008051568A3 (fr) Procédés et compositions pour le traitement de déficits osseux au moyen de populations de cellules placentaires
WO2008118392A3 (fr) Plate-formes synthétiques de cellules et leurs procédés d'utilisation
WO2012149480A3 (fr) Systèmes et procédés d'imagerie in vitro et in vivo de cellules sur un substrat
WO2007146334A3 (fr) Équivalent de tissu lymphoïde (etl) issu d'une co-culture destiné à un système immunitaire artificiel (sia)
WO2012135621A3 (fr) Amorçage de cellules souches pluripotentes pour la différentiation neurale
MX2009014273A (es) Metodos y composiciones para expansion e implantacion optimizadas de celulas madre mesenquimales.
WO2007127927A3 (fr) Différentiation de cellules souches embryonnaires humaines
WO2009151907A3 (fr) Compositions et procédés permettant d'utiliser des cellules pour traiter le tissu cardiaque
WO2012062810A3 (fr) Milieu de culture de cellules et procédé pour l'expression d'une protéine, lesdits milieu et procédé comprenant un inhibiteur de la pam
SG196784A1 (en) Stem cell cultures
PL2274419T3 (pl) Sposoby wytwarzania mikromieszków włosowych i brodawek de novo i stosowanie ich w badaniach in vitro i przeszczepach in vivo
NZ593365A (en) Pharmaceutical preparation comprising a blood mononuclear cell culture
WO2010020876A3 (fr) Procédé de culture cellulaire
WO2012092542A3 (fr) Hydrogel de culture cellulaire sensible
WO2011105821A3 (fr) Composition de culture de cellules souches exempte de sérum, composition de régénération tissulaire contenant celle-ci et procédé de régénération tissulaire l'utilisant
WO2008150001A1 (fr) Amas adipeux
WO2011060357A3 (fr) Cellules xénogéniques modifiées pour la réparation d'un tissu biologique
WO2009035612A3 (fr) Cellules souches pluripotentes et leurs utilisations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10779041

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010779041

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13497707

Country of ref document: US